Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver Transplantation
Background. The cytoprotective effects of hemeoxygenase-1 and its product biliverdin/bilirubin are widely acknowledged in experimental transplant medicine. However, its potentially beneficial effect during organ reperfusion is not established. Methods. In a matched study, we compared markers of repe...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2017-08-01
|
Series: | Transplantation Direct |
Online Access: | http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000684 |
_version_ | 1811330968116527104 |
---|---|
author | Vinzent Spetzler, MD Nicolas Goldaracena, MD Johann Moritz Kaths, MD Max Marquez, MD Markus Selzner, MD Nazia Selzner, MD, PhD |
author_facet | Vinzent Spetzler, MD Nicolas Goldaracena, MD Johann Moritz Kaths, MD Max Marquez, MD Markus Selzner, MD Nazia Selzner, MD, PhD |
author_sort | Vinzent Spetzler, MD |
collection | DOAJ |
description | Background. The cytoprotective effects of hemeoxygenase-1 and its product biliverdin/bilirubin are widely acknowledged in experimental transplant medicine. However, its potentially beneficial effect during organ reperfusion is not established.
Methods. In a matched study, we compared markers of reperfusion injury (alanine aminotransferase/aspartate aminotransferase) and transplantation outcome (complication rates, liver function, and survival) between recipient groups with “normal” versus “increased” preoperative bilirubin values. Groups were matched for donor and recipient age, liver disease, year of transplantation, and recipient’s preoperative condition (modified model for end-stage liver disease score excluding bilirubin).
Results. The postoperative transaminase peak was significantly higher when comparing the “normal” to the “increased” bilirubin group (maximum aspartate aminotransferase “normal” 2013 [325-13 210] U/L vs “increased” 1360 [221-15 460] U/L, P = 0.006; maximum alanine aminotransferase “normal” 1151 [82-6595] U/L vs “increased” 820 [66-5382] U/L, P = 0.01). Grafts in the “increased” bilirubin group had faster recovery of graft function with faster decrease in international normalized ratio at days 3 and 7 posttransplantation in the “increased” vs “normal” bilirubin group. Although long-term functional parameters (international normalized ratio and bilirubin posttransplantation) as well as surgical and biliary complication rates were similar in both groups, 1-year survival rates were significantly higher in the group with increased preoperative bilirubin (graft survival, “normal” 86% vs “increased” 97%; P = 0.006).
Conclusions. Increased bilirubin levels of liver graft recipients before transplantation are associated with reduced reperfusion injury and improved survival after transplantation. |
first_indexed | 2024-04-13T16:10:46Z |
format | Article |
id | doaj.art-57729e6b681149368d2a150bb8e7f7d3 |
institution | Directory Open Access Journal |
issn | 2373-8731 |
language | English |
last_indexed | 2024-04-13T16:10:46Z |
publishDate | 2017-08-01 |
publisher | Wolters Kluwer |
record_format | Article |
series | Transplantation Direct |
spelling | doaj.art-57729e6b681149368d2a150bb8e7f7d32022-12-22T02:40:14ZengWolters KluwerTransplantation Direct2373-87312017-08-0138e18710.1097/TXD.0000000000000684201708000-0009Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver TransplantationVinzent Spetzler, MD0Nicolas Goldaracena, MD1Johann Moritz Kaths, MD2Max Marquez, MD3Markus Selzner, MD4Nazia Selzner, MD, PhD51 Department of Surgery, Multi Organ Transplant Program, Toronto General Hospital, University of Toronto, Toronto, Canada.1 Department of Surgery, Multi Organ Transplant Program, Toronto General Hospital, University of Toronto, Toronto, Canada.1 Department of Surgery, Multi Organ Transplant Program, Toronto General Hospital, University of Toronto, Toronto, Canada.1 Department of Surgery, Multi Organ Transplant Program, Toronto General Hospital, University of Toronto, Toronto, Canada.1 Department of Surgery, Multi Organ Transplant Program, Toronto General Hospital, University of Toronto, Toronto, Canada.2 Department of Medicine, Multi Organ Transplant Program, Toronto General Hospital, University of Toronto, Toronto, Canada.Background. The cytoprotective effects of hemeoxygenase-1 and its product biliverdin/bilirubin are widely acknowledged in experimental transplant medicine. However, its potentially beneficial effect during organ reperfusion is not established. Methods. In a matched study, we compared markers of reperfusion injury (alanine aminotransferase/aspartate aminotransferase) and transplantation outcome (complication rates, liver function, and survival) between recipient groups with “normal” versus “increased” preoperative bilirubin values. Groups were matched for donor and recipient age, liver disease, year of transplantation, and recipient’s preoperative condition (modified model for end-stage liver disease score excluding bilirubin). Results. The postoperative transaminase peak was significantly higher when comparing the “normal” to the “increased” bilirubin group (maximum aspartate aminotransferase “normal” 2013 [325-13 210] U/L vs “increased” 1360 [221-15 460] U/L, P = 0.006; maximum alanine aminotransferase “normal” 1151 [82-6595] U/L vs “increased” 820 [66-5382] U/L, P = 0.01). Grafts in the “increased” bilirubin group had faster recovery of graft function with faster decrease in international normalized ratio at days 3 and 7 posttransplantation in the “increased” vs “normal” bilirubin group. Although long-term functional parameters (international normalized ratio and bilirubin posttransplantation) as well as surgical and biliary complication rates were similar in both groups, 1-year survival rates were significantly higher in the group with increased preoperative bilirubin (graft survival, “normal” 86% vs “increased” 97%; P = 0.006). Conclusions. Increased bilirubin levels of liver graft recipients before transplantation are associated with reduced reperfusion injury and improved survival after transplantation.http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000684 |
spellingShingle | Vinzent Spetzler, MD Nicolas Goldaracena, MD Johann Moritz Kaths, MD Max Marquez, MD Markus Selzner, MD Nazia Selzner, MD, PhD Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver Transplantation Transplantation Direct |
title | Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver Transplantation |
title_full | Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver Transplantation |
title_fullStr | Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver Transplantation |
title_full_unstemmed | Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver Transplantation |
title_short | Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver Transplantation |
title_sort | elevated preoperative serum bilirubin improves reperfusion injury and survival postliver transplantation |
url | http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000684 |
work_keys_str_mv | AT vinzentspetzlermd elevatedpreoperativeserumbilirubinimprovesreperfusioninjuryandsurvivalpostlivertransplantation AT nicolasgoldaracenamd elevatedpreoperativeserumbilirubinimprovesreperfusioninjuryandsurvivalpostlivertransplantation AT johannmoritzkathsmd elevatedpreoperativeserumbilirubinimprovesreperfusioninjuryandsurvivalpostlivertransplantation AT maxmarquezmd elevatedpreoperativeserumbilirubinimprovesreperfusioninjuryandsurvivalpostlivertransplantation AT markusselznermd elevatedpreoperativeserumbilirubinimprovesreperfusioninjuryandsurvivalpostlivertransplantation AT naziaselznermdphd elevatedpreoperativeserumbilirubinimprovesreperfusioninjuryandsurvivalpostlivertransplantation |